{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:39:14Z","timestamp":1768822754983,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,6,9]],"date-time":"2013-06-09T00:00:00Z","timestamp":1370736000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2013,6]]},"abstract":"Abstract<\/jats:title>Background<\/jats:title>There are few current data on the prevalence of hyperuricaemia and gout in N<\/jats:styled-content>ew Z<\/jats:styled-content>ealand, particularly among the indigenous M<\/jats:styled-content>\u0101ori population.<\/jats:p><\/jats:sec>Aims<\/jats:title>To determine the prevalence of gout and hyperuricaemia in rural and urban M<\/jats:styled-content>\u0101ori and non\u2010M\u0101ori community samples and describe the treatment and comorbidities of participants with gout.<\/jats:p><\/jats:sec>Methods<\/jats:title>Participants aged 20\u201364 years were recruited by random selection from the electoral roll. M<\/jats:styled-content>\u0101ori samples were selected from among those identified as being of M<\/jats:styled-content>\u0101ori descent on the roll and who self\u2010identified as being of M<\/jats:styled-content>\u0101ori ethnicity at interview. Personal medical history, blood pressure, anthropometrics, fasting lipids, glucose, HbA1c<\/jats:styled-content> and urate were recorded.<\/jats:p><\/jats:sec>Results<\/jats:title>There were 751 participants. Mean serum urate (SU<\/jats:styled-content>) was 0.30\u2009mmol\/L (0.06\u20130.69\u2009mmol\/L). M<\/jats:styled-content>\u0101ori had a significantly higher prevalence of hyperuricaemia (SU<\/jats:styled-content> > 0.40\u2009mmol\/L) compared with non\u2010M<\/jats:styled-content>\u0101ori (17.0% vs 7.5%, P<\/jats:styled-content><\/jats:italic> = 0.0003). A total of 57 participants had a history of gout, with a higher prevalence in M<\/jats:styled-content>\u0101ori compared with non\u2010M<\/jats:styled-content>\u0101ori (10.3% vs 2.3%, P<\/jats:styled-content><\/jats:italic> < 0.0001). Of the participants, 18\/57 (31.6%) with gout were receiving urate\u2010lowering therapy, but in 38.9%, SU<\/jats:styled-content> was >0.36\u2009mmol\/L. Participants with gout were more likely to have metabolic syndrome, diabetes, cardiac disease or hypertension.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Gout and hyperuricaemia were more prevalent in M<\/jats:styled-content>\u0101ori, and participants with gout were more likely to have comorbidities. There was not a higher overall adjusted cardiovascular disease risk in M<\/jats:styled-content>\u0101ori participants with gout. Despite the high prevalence of gout, management remains suboptimal.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.12062","type":"journal-article","created":{"date-parts":[[2012,12,24]],"date-time":"2012-12-24T11:16:06Z","timestamp":1356347766000},"page":"678-684","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hyperuricaemia and gout in N<\/scp>ew Z<\/scp>ealand rural and urban M<\/scp>\u0101ori and non\u2010M<\/scp>\u0101ori communities"],"prefix":"10.1111","volume":"43","author":[{"given":"L. K.","family":"Stamp","sequence":"first","affiliation":[{"name":"Department of Medicine University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Public Health and General Practice University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pitama","sequence":"additional","affiliation":[{"name":"M\u0101ori Indigenous Health Institute University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faatoese","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Doughty","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Whalley","sequence":"additional","affiliation":[{"name":"Faculty of Social and Health Sciences Unitec Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Otago Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80158-3"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem056a"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.1.22"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker361"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.06.040"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.356"},{"key":"e_1_2_7_9_1","first-page":"1882","article-title":"Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome","volume":"334","author":"Hjortnaes J","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.034"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22014"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.703389"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.03.043"},{"key":"e_1_2_7_14_1","first-page":"73","article-title":"Cardiovascular disease risk factor assessment and management in gout; an alaysis using guideline\u2010based electronic clinical decision support","volume":"121","author":"Colvine K","year":"2008","journal-title":"N Z Med J"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2011.00702.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2011.00777.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080504"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.35"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000799"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.19.2.120"},{"key":"e_1_2_7_21_1","first-page":"295","article-title":"Uric acid, gout and public health in the South Pacific","volume":"65","author":"Prior I","year":"1966","journal-title":"N Z Med J"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60391-1"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.08.037"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-007-9253-3"},{"key":"e_1_2_7_26_1","first-page":"301","article-title":"Trends in hyperuricaemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993\u20131996 to 2005\u20132008","volume":"20","author":"Chuang S","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.09.003"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3199"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200320"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100418"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.12062","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.12062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:56:20Z","timestamp":1697352980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.12062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/imj.12062"],"URL":"https:\/\/doi.org\/10.1111\/imj.12062","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"2012-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}